Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
Brown SA
,
Hanscom HN
,
Vu H
,
Brew SA
,
Winkles JA
.
???displayArticle.abstract???
TWEAK [TNF (tumour necrosis factor)-like weak inducer of apoptosis] is a member of the TNF superfamily of cytokines. TWEAK binds with high affinity to a single TNF receptor super-family member, Fn14 (fibroblast growth factor-inducible 14). This interaction can stimulate a variety of biological responses, depending on the cell type analysed. The murine Fn14 extracellular region is only 53 amino acids in length and primarily consists of a CRD (cysteine-rich domain) containing three disulphide bonds. In the present study, we investigated whether TWEAK binding to this CRD was dependent on selected evolutionarily conserved amino acid residues by using a site-specific mutagenesis approach and several different ligand-binding assays. Our results indicate that three residues within the predicted Fn14 CRD A1 module (Asp45, Lys48 and Met50) and one residue within the predicted D2 module (Asp62) are each critical for high-affinity TWEAK binding. Mutation of the three charged polar residues Asp45, Lys48 and Asp62 had the greatest deleterious effect, suggesting that electrostatic interactions between TWEAK and Fn14 residues may be particularly important for complex formation or stability. To determine whether the four critical residues were likely to be located on the Fn14 CRD surface, we made an Fn14 homology model based on a previously derived X-ray structure for the B-cell maturation antigen receptor, which also contains only one CRD. This model revealed that each of these critical residues were in areas of the receptor that are potentially capable of interacting with TWEAK. These results indicate that the TWEAK-Fn14 interaction is highly dependent on multiple Fn14 residues located in both CRD modules.
Bodmer,
The molecular architecture of the TNF superfamily.
2002, Pubmed
Bodmer,
The molecular architecture of the TNF superfamily.
2002,
Pubmed
Brown,
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.
2003,
Pubmed
Campbell,
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
2006,
Pubmed
Campbell,
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
2004,
Pubmed
Chicheportiche,
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.
2002,
Pubmed
Chicheportiche,
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis.
1997,
Pubmed
Donohue,
TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity.
2003,
Pubmed
Feng,
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.
2000,
Pubmed
Gordon,
BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
2003,
Pubmed
Han,
TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors.
2003,
Pubmed
Harada,
Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.
2002,
Pubmed
Hehlgans,
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.
2005,
Pubmed
Ho,
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
1989,
Pubmed
Ho,
Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
2004,
Pubmed
Hymowitz,
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
2005,
Pubmed
Jakubowski,
Dual role for TWEAK in angiogenic regulation.
2002,
Pubmed
Jakubowski,
TWEAK induces liver progenitor cell proliferation.
2005,
Pubmed
Jin,
Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes.
2004,
Pubmed
Kayagaki,
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
2002,
Pubmed
Kim,
Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
2003,
Pubmed
Liu,
Ligand-receptor binding revealed by the TNF family member TALL-1.
2003,
Pubmed
Locksley,
The TNF and TNF receptor superfamilies: integrating mammalian biology.
2001,
Pubmed
Lynch,
TWEAK induces angiogenesis and proliferation of endothelial cells.
1999,
Pubmed
Meighan-Mantha,
The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration.
1999,
Pubmed
Michaelson,
Tweak induces mammary epithelial branching morphogenesis.
2005,
Pubmed
Mueller,
Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
2005,
Pubmed
Naismith,
Modularity in the TNF-receptor family.
1998,
Pubmed
Nakayama,
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
2003,
Pubmed
Patel,
Engineering an APRIL-specific B cell maturation antigen.
2004,
Pubmed
Polek,
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
2003,
Pubmed
Potrovita,
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
2004,
Pubmed
Saas,
TWEAK stimulation of astrocytes and the proinflammatory consequences.
2000,
Pubmed
Saitoh,
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
2003,
Pubmed
Tran,
The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.
2003,
Pubmed
Tran,
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
2005,
Pubmed
Ware,
The TNF superfamily.
2003,
Pubmed
Wiley,
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.
2001,
Pubmed
Wiley,
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
2003,
Pubmed
Xu,
TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
2004,
Pubmed
Yepes,
A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.
2005,
Pubmed
